Compare ALLO & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | ATLO |
|---|---|---|
| Founded | 2017 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 205.2M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | ATLO |
|---|---|---|
| Price | $1.48 | $25.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $8.27 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 23.5K |
| Earning Date | 03-12-2026 | 01-23-2026 |
| Dividend Yield | N/A | ★ 3.30% |
| EPS Growth | N/A | ★ 88.22 |
| EPS | N/A | ★ 2.14 |
| Revenue | N/A | ★ $65,795,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.35 |
| Revenue Growth | N/A | ★ 23.09 |
| 52 Week Low | $0.86 | $16.09 |
| 52 Week High | $3.78 | $24.96 |
| Indicator | ALLO | ATLO |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 74.71 |
| Support Level | $1.54 | $24.00 |
| Resistance Level | $1.83 | $24.96 |
| Average True Range (ATR) | 0.13 | 0.62 |
| MACD | -0.00 | 0.14 |
| Stochastic Oscillator | 25.23 | 95.61 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.